Impact of the COVID-19 Pandemic on Photodynamic Therapy Utilization in the Medicare Population: A Medicare Part B Claims Analysis
Journal of the American Academy of Dermatology · 2026-11
DOI: 10.1016/j.jaad.2026.11.050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-11. Verfasst von Sophia Neman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI.
- Department of Dermatology, Yale School of Medicine, New Haven, CT. Electronic address: Nelson.ugwu@yale.edu.
- Department of Dermatology, Yale School of Medicine, New Haven, CT.
Zitieren
APA
Neman, S., Ugwu, N., & Suozzi, K. (2026). Impact of the COVID-19 Pandemic on Photodynamic Therapy Utilization in the Medicare Population: A Medicare Part B Claims Analysis. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.11.050
Vancouver
Neman S, Ugwu N, Suozzi K. Impact of the COVID-19 Pandemic on Photodynamic Therapy Utilization in the Medicare Population: A Medicare Part B Claims Analysis. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.11.050
BibTeX
@article{Neman2026,
author = {Neman, Sophia and Ugwu, Nelson and Suozzi, Kathleen},
title = {Impact of the COVID-19 Pandemic on Photodynamic Therapy Utilization in the Medicare Population: A Medicare Part B Claims Analysis},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.11.050}
}
EUVIMED